Results 81 to 90 of about 25,866 (234)

Long‐Term Outcomes of Radiofrequency Atrioventricular Node Ablation in a Real‐World Population

Pacing and Clinical Electrophysiology, EarlyView.
Abstract Background While interventional strategies have expanded the options for long term rhythm restoration, rate control continues to play a pivotal role in the treatment of atrial arrhythmias; however, pharmacologic strategies alone often fail in achieving effective rate control.
Vanessa Sciacca, Nora‐Kristin Brandt, Thomas Fink, Denise Guckel, Maximilian Mörsdorf, Yuri Bocchini, Martin Braun, Moneeb Khalaph, Karen Harutyunyan, Nadica Trajkovska, Philipp Lucas, Thomas Eitz, Maxim Didenko, Philipp Sommer, Christian Sohns   +14 more
wiley   +1 more source

Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy [PDF]

, 2008
Ignacio García‐Bolao, Begoña López, Alfonso Macı́as, Juán José Gavira, Pedro Azcárate, Javier Dı́ez   +5 more
openalex   +1 more source

1033 A STRANGE CASE OF PULMONARY EMBOLISM IN A YOUNG PATIENT WITH CARDIAC RESYNCHRONIZATION THERAPY [PDF]

, 2022
Davide Restelli, Cristina Poleggi, Alessandro Di Carlo, Giuseppe Pelaggi, Gianluca Di Bella, Antonio Micari, Marco Bonanno, Maria Paola Trifirò, Giuseppe Paleologo, Scipione Carerj   +9 more
openalex   +1 more source

60. Mid-term outcome of cardiac resynchronization therapy in pediatrics: single institution experience

Journal of the Saudi Heart Association, 2016
Cardiac resynchronization therapy (CRT) has become an increasingly important therapeutic option for patients (pts) to treat dyssynchrony associated moderate and severe heart failure.
T. Jawadi, W. Manea, M. Alahmadi, G. Salvo, M. Al Fayyadh   +4 more
doaj   +1 more source

Association of ABO blood group and coronary heart disease in blood donors—Results from a cohort study in Australia

Transfusion, EarlyView.
Abstract Background ABO blood groups may be associated with increased risk for several diseases including cardiovascular diseases (CVDs), particularly coronary heart disease (CHD). The role of other significant blood group systems, such as RhD and RhCE, has not been extensively investigated.
Surendra Karki, Katy Bell, David O. Irving, Marijke Welvaert, Rena Hirani   +4 more
wiley   +1 more source

Cardiac resynchronization therapy in a young patient with Duchenne muscular dystrophy

International Medical Case Reports Journal, 2015
Tamami Kono,1 Akiyoshi Ogimoto,1 Kazuhisa Nishimura,1 Toshihiro Yorozuya,2 Takafumi Okura,1 Jitsuo Higaki1 1Department of Cardiology, Pulmonology, Hypertension and Nephrology, 2Department of Anesthesiology and Resuscitology, Ehime University Graduate ...
Kono T, Ogimoto A, Nishimura K, Yorozuya T, Okura T, Higaki J   +5 more
doaj  

Advances in cardiac devices and bioelectronics augmented with artificial intelligence

The Journal of Physiology, EarlyView.
Abstract figure legend Interfaces between the human heart, diagnostic bioelectronics, artificial intelligence, and clinical care. From left to right: Human heart and biosensor interface; representative waveforms of common diagnostic bioelectronic sensing modalities.
Charles Stark, Eric Rytkin, Andrei Alexandru Mircea, Igor R. Efimov   +3 more
wiley   +1 more source

Combined preoperative information using a bullseye plot from speckle tracking echocardiography, cardiac CT scan, and MRI scan: targeted left ventricular lead implantation in patients receiving cardiac resynchronization therapy [PDF]

, 2013
Z. Bakos, Hanna Markstad, Ellen Ostenfeld, Marcus Carlsson, Anders Roijer, Rasmus Borgquist   +5 more
openalex   +1 more source

Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis

Hellenic Journal of Cardiology, 2019
Background: Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) reduce sudden cardiac death and all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF).
Ahmed AlTurki, Riccardo Proietti, Hasan Alturki, Vidal Essebag, Thao Huynh   +4 more
doaj   +1 more source

Cardiac remodelling in type 2 diabetes: Pathophysiological mechanisms and opportunities for multiscale computational modelling and simulation

The Journal of Physiology, EarlyView.
Abstract figure legend Overview of multiscale cardiac remodelling in type 2 diabetes and how to model and simulate these changes using a human‐based, multiscale computational framework. Cardiac remodelling in type 2 diabetes occurs at ionic channel, protein, cellular, tissue and whole‐organ level, affecting the electrophysiological function, mechanical
Ambre Bertrand, Jakub Tomek, Blanca Rodriguez   +2 more
wiley   +1 more source